Effect of somatostatin versus octreotide on portal haemodynamics in patients with cirrhosis and portal hypertension

ObjectivesElevated portal inflow is part of the pathogenesis of portal hypertension in patients with cirrhosis. Vasoactive substances appear to play a primary role in the regulation of portal flow. The aim of this study was to investigate the effects of somatostatin and octreotide on portal pressure